Jp. Qu et al., Expression of receptors for insulin-like growth factor-I and transforming growth factor-beta in human follicles, MOL HUM REP, 6(2), 2000, pp. 137-145
The in-vitro growth of immature oocytes in early follicles from cryopreserv
ed human ovarian tissues is a new concept in in-vitro fertilization program
mes for the treatment of infertile and cancer patients. To better understan
d the regulatory mechanism of follicular development, immunohistochemistry
was used to study the expression of insulin-like growth factor (IGF) type I
receptor (IGF-IR) and transforming growth factor-beta (TGF beta) type I (T
beta R-I) and type II (T beta R-II) receptors in fresh and frozen ovarian
tissues from 14 women. Immunoreactivities for IGF-IR and T beta R-I were pr
esent simultaneously in the oocytes of primordial, pre-antral and antral fo
llicles. Staining for both IGF-IR and T beta R-I was also observed in granu
losa cells of primordial, pre-antral and antral follicles. IGF-IR and T bet
a R-I also stained in thecal cells of pre-antral and antral follicles. Stro
mal cells in surrounding ovarian tissue expressed IGF-IR and T beta R-I at
various follicular stages. Unlike T beta R-I, T beta R-II was expressed onl
y in the oocytes of primordial and primary follicles, and with weak stainin
g intensity in thecal cells. No significant staining for T beta R-II was fo
und in oocytes and granulosa cells of antral follicles. There was no differ
ence in staining patterns far IGF-IR, T beta R-I and T beta R-II between fr
esh and frozen ovarian tissues, indicating that cryopreservation might not
significantly alter the immunoreactivities of these receptors in frozen ova
rian tissue. The results suggest that IGF-I and TGF beta may participate in
the regulation of follicular growth by binding to their receptors through
an autocrine or paracrine mechanism. IGF-I and TGF beta may be useful in re
gulating the in-vitro or in-vivo maturation of oocytes not only in later fo
llicles but also very early follicles, from cryopreserved ovarian tissues f
or clinical use in the future.